Skip to main content
Home / Current Drug Targets, Volume 11, Number 1
Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will be devoted to a single timely topic, with series of in-depth reviews, written by leaders in the field, covering a range of current topics on drug targets. These issues will be organized and led by a guest editor who is a recognized expert in the overall topic. As the discovery, identification, characterisation and validation of novel human drug targets for drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

More about this publication?
Volume 11, Number 1, 2010

Articles

Free Content Editorial [Hot topic: The Role of Pemetrexed in Lung Cancer (Guest Editors: Daoyuan Wang and Jianxing He)]
pp. 1-1(1)
Authors: Wang, Daoyuan; He, Jianxing

Favourites:
ADD

The Role of Pemetrexed Combined with Targeted Agents for Non-Small Cell Lung Cancer
pp. 2-11(10)
Authors: Konopa, Krzysztof; Jassem, Jacek

Favourites:
ADD

Pharmacological Aspects of the Enzastaurin-Pemetrexed Combination in Non-Small Cell Lung Cancer (NSCLC)
pp. 12-28(17)
Authors: Giovannetti, Elisa; Honeywell, Richard; Hanauske, Axel R.; Tekle, Christina; Kuenen, Bart; Sigmond, Jennifer; Giaccone, Giuseppe; Peters, Godefridus J.

Favourites:
ADD

Role of Pemetrexed and Platinums Combination in Patients with Non- Small Cell Lung Cancer
pp. 29-36(8)
Authors: Chen, Manyin; Shao, Wenlong; He, Jianxing; Wang, Daoyuan

Favourites:
ADD

The Role of Pemetrexed in Advanced Non Small-Cell Lung Cancer: Special Focus on Pharmacology and Mechanism of Action
pp. 37-47(11)
Authors: Joerger, M.; Omlin, A.; Cerny, T.; Fruh, M.

Favourites:
ADD

Predictive Markers for Haematological Toxicity of Pemetrexed
pp. 48-57(10)
Authors: Kao, S. C.H.; Phan, V. H.; Clarke, S. J.

Favourites:
ADD

The Role of Pemetrexed in Second-Line Chemotherapy for Advanced Non-Small Cell Lung Cancer
pp. 58-60(3)
Author: Tucker, Steven

Favourites:
ADD

The Role of Pemetrexed Combined with Gemcitabine for Non-Small-Cell Lung Cancer
pp. 61-66(6)
Authors: Ngeow, Joanne; Toh, Chee-Keong

Favourites:
ADD

The Role of Chemotherapy and Radiation in the Treatment of Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
pp. 67-73(7)
Authors: Wagner, Timothy D.; Yang, Gary Y.

Favourites:
ADD

The Role of Pemetrexed in Lung Adenocarcinoma, Mixed Subtype with Bronchioloalveolar Carcinoma Features
pp. 74-77(4)
Authors: Duruisseaux, Michael; Cadranel, Jacques; Perol, Maurice; Arpin, Dominique

Favourites:
ADD

Pemetrexed: Potential Role in the Adjuvant Chemotherapy of Non-Small Cell Lung Cancer
pp. 78-84(7)
Author: Vincent, Mark

Favourites:
ADD

Intercalation of Erlotinib and Pemetrexed in the Treatment of Non-Small Cell Lung Cancer
pp. 85-94(10)
Authors: Li, Tianhong; Lara Jr., Primo N.; Mack, Philip C.; Perez-Soler, Roman; Gandara, David R.

Favourites:
ADD

Targeted Elimination of Leukemia Stem Cells; a New Therapeutic Approach in Hemato-Oncology
pp. 95-110(16)
Authors: Cate, B. t.; de Bruyn, M.; Wei, Y.; Bremer, E.; Helfrich, W.

Favourites:
ADD

Coenzyme Q10 in Neuromuscular and Neurodegenerative Disorders
pp. 111-121(11)
Authors: Mancuso, M.; Orsucci, D.; Volpi, L.; Calsolaro, V.; Siciliano, G.

Favourites:
ADD

Should Adipokines be Considered in the Choice of the Treatment of Obesity-Related Health Problems?
pp. 122-135(14)
Authors: Athyros, Vasilios G.; Tziomalos, Konstantinos; Karagiannis, Asterios; Anagnostis, Panagiotis; Mikhailidis, Dimitri P.

Favourites:
ADD

Share Content

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content